Resistance from the flanks: A role for telomere repeat factor 2 in chemotherapeutic drug resistance

Cancer Biology and Therapy

Volumn 5, Issue 8, 2006, Pages 957-958

  Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Adriamycin; DNA damage; Drug resistance; Etoposide; TRF2

Indexed keywords

EID: 33751421776     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.8.3284     Document Type: Note

References (15)

1. Bradshaw PS, Stavropoulos DJ and Meyn MS. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 2005;37:193-7.
2. Celli GB and de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 2005; 7:712-8.
3. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10.
4. Harrison JC and Haber JE. Surviving the breakup: The DNA damage checkpoint. Annu Rev Genet 2006; In press.
5. Karlseder J, Broccoli D, Dai Y, Hardy S and de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283:1321-5.
6. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH and de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol 2004; 2:E240.
7. Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K, Chayama K, Yasui W and Tahara E. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Int J Oncol 2001; 19:507-12.
8. Munoz P, Blanco R and Blasco MA. Role of the TRF2 telomeric protein in cancer and ageing. Cell Cycle 2006; 5:718-21.
9. Munoz P, Blanco R, Flores JM and Blasco MA. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat Genet 2005; 37:1063-71.
10. Nijjar T, Bassett E, Garbe J, Takenaka Y, Stampfer MR, Gilley D and Yaswen P. Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene 2005; 24:3369-76.
11. Ning H, Li T, Zhao L, Li T, Li J, Liu J, Liu Z and Fan D. TRF2 Promotes Multidrug Resistance in Gastric Cancer Cells. Cancer Biol Ther 2006; 5:950-6.
12. Oh BK, Kim YJ, Park C and Park YN. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 2005; 166:73-80.
13. van Steensel B, Smogorzewska A and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92:401-13.
14. Wang RC, Smogorzewska A and de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004; 119:355-68.
15. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH and de Lange T. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003; 12:1489-98.